-
Bharat Biotech stated it is an innovator, vaccine developer and manufacturer and safety of vaccines is its primary objective, followed by efficacy
-
The envoys will make a visit to Bharat Biotech and BE limited which are working on the Covid-19 vaccine.
-
Hyderabad: The Greater Hyderabad Municipal Corporation election is turning out to be the mother of all polls, for the sheer political heat it has generated and the galaxy of leaders campaigning for the BJP. Saturday, the penultimate day of campaign saw electioneering reach a crescendo with Chief Minister K Chandrashekhar Rao leading the field for […]
-
BJP leader remained mum on the State govt's demand that vaccine from Hyderabad-based pharma major should first be released to the people of the State
-
Takes stock of the progress made by the Hyderabad-based company in the trials of Covaxin, jointly developed with ICMR-National Institute of Virology
-
He was received by Chief Secretary Somesh Kumar, DGP M Mahender Reddy and three other officials on behalf of the State government.
-
He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the Air Force base, officials said.
-
Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad in the morning.
-
Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.
-
The State government’s demand comes on the eve of the Prime Minister’s visit to the Bharat Biotech campus on Saturday
-
Zydus Cadila had announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.
-
Modi will be arriving at Hakimpet Air Force station in an IAF flight from Pune in the afternoon, an official memo issued by the Telangana Chief Secretary on Thursday night said.
-
The Hyderabad-based firm, while applying for phase-three trial, stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported.
-
He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today.
-
Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.
-
The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR
-
According to Microsoft, among the targets, the majority are vaccine makers that have Covid-19 vaccines in various stages of clinical trials
-
Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and manufacturing capabilities of developed and developing countries. Speaking at the 28th Annual Hysea Innovation Summit, Bharat Biotech MD Dr Krishna Ella said that the pandemic vaccine coming out in 12 months […]
-
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)
-
Hyderabad-headquartered company is currently conducting Phase II human trials of Covaxin after receiving Drug Controller General of India nod
